Skip to content

In situ diagnosis of glioma based on Raman detection

In situ diagnosis of glioma based on Raman detection

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051517
Enrollment
Unknown
Registered
2021-09-25
Start date
2021-09-24
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Gold Standard:pathologic diagnosis
diagnosis&#32
of&#32
based&#32
on&#32
detection

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with glioma confirmed by cranial MRI and treated with surgery; 2. MRI suggests convex glioma (non-deep brain lesions) with a diameter greater than 2cm; 3. Aged 18 to 85 years; 4. Sign the informed consent form with full knowledge.

Exclusion criteria

Exclusion criteria: 1. Disagree with the participants; 2. Vulnerable groups, such as pregnant women, children and adolescents, etc.; 3. Those with poor physiological and pathological conditions.

Design outcomes

Primary

MeasureTime frame
Raman value;pathologic diagnosis;

Countries

China

Contacts

Public ContactYou Yongping

The First Affiliated Hospital of Nanjing Medical University

YYPL9@njmu.edu.cn+86 13770694258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026